Stay updated on NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record. The prior list of documents and related metadata appears removed or hidden, indicating an access-restriction state.SummaryDifference20%

- Check36 days agoChange DetectedA funding reference, noting the 2018 U.S. NIH Grant/Contract, was added to the study identifiers. The page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This appears to be a minor site update and does not modify the study details.SummaryDifference0.0%

- Check72 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a newer version of the study details page.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page revision stamp was updated to v3.6.3, replacing the previous v3.6.2. This indicates a general update to the page without altering the study data.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing v3.6.0, indicating a site update. The study content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.